Genome-Edited Coincidence and PMP22-HiBiT Fusion Reporter Cell Lines Enable an Artifact-Suppressive Quantitative High-Throughput Screening Strategy for PMP22 Gene-Dosage Disorder Drug Discovery-Reference-Cited by-同舟云学术

Genome-Edited Coincidence and PMP22-HiBiT Fusion Reporter Cell Lines Enable an Artifact-Suppressive Quantitative High-Throughput Screening Strategy for PMP22 Gene-Dosage Disorder Drug Discovery

Published:2021-06-10 Issue:4 Volume:4 Page:1422-1436
ISSN:2575-9108
Container-title:ACS Pharmacology & Translational Science
language:en
Short-container-title:ACS Pharmacol. Transl. Sci.

Author:

Martinez Natalia J.¹^ORCID,Braisted John C.¹,Dranchak Patricia K.¹^ORCID,Moran John J.²,Larson Hunter¹,Queme Bryan¹,Pak Evgenia³,Dutra Amalia³,Rai Ganesha¹^ORCID,Cheng Ken Chih-Chien¹,Svaren John²,Inglese James¹³^ORCID

Affiliation:

1. National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland 20850, United States

2. Department of Comparative Biosciences, and Waisman Center, University of Wisconsin, Madison, Wisconsin 53705, United States

3. National Human Genome Research Institute, National Institute of Health, Bethesda, Maryland 20817, United States

Funder

National Center for Advancing Translational Sciences

National Institute of Neurological Disorders and Stroke

Publisher

American Chemical Society (ACS)

Subject

Pharmacology (medical),Pharmacology

Link